Quality-screened international income — lumpy, real, compounding. A 3.49% trailing yield from about 199 non-U.S. companies screened for dividend quality and financial strength, at a 0.47% expense ratio, with a trailing-12-month distribution total of $1.40 ($0.2261 in December 2025, $0.1152 in March 2026, $0.5948 in June 2026, $0.4601 in September 2026) at the $40.01 close on October 23, 2026. The payout is funded by the holdings’ dividends, not leverage or options, and the long window clears the trap check: the price is up about 70% over ten years, so distributions have been paid on top of growth, not carved out of principal. Budget on the trailing twelve months, not on any single quarter — the quarterly amounts swing from $0.12 to $0.59 because the underlying payers cluster their dividends.
Key risk: Small-fund liquidity and concentration — at roughly $105 million in assets with only a few thousand shares trading most days, this fund is far thinner than its peers, so large orders can move the price; financials are about 29% of the portfolio and Asia is about 46% of the regions, so a banking downturn or an Asia-driven selloff moves it more than a global fund, and the 0.47% fee takes about an eighth of the trailing yield.
Changes if: Trailing-12-month distributions fall for two consecutive quarters, or the expense ratio rises materially. Quarterly lumpiness alone is not a tripwire — the trailing total is.
- ✓Yield check: 3.49% trailing — $1.40 of distributions over the trailing 12 months ($0.2261 plus $0.1152 plus $0.5948 plus $0.4601) at the $40.01 close on October 23, 2026. That sits in the moderate-yield band for an international dividend fund — income with growth still attached.
- !Expense check: 0.47% a year is nearly eight times SCHD’s 0.06%. Quality screening across international markets is what the extra fee buys — judge whether it is worth it, and note it consumes roughly an eighth of the trailing yield.
- !Distribution-pattern check: Quarterly amounts swing from $0.12 to $0.59 because the underlying payers cluster their dividends — the income is real, but a single quarter says almost nothing about the run rate; the $1.40 trailing total is the figure to watch.
- !Liquidity check: About $105 million in assets and only a few thousand shares a day is thin for a core holding — fine for a patient holder buying in small size, but a large order can move the price against the buyer.
- ✓Trap check — distribution vs. total return: Passed — the price is up about 70% over ten years despite roughly 3–4% annual distributions: the distributions were paid on top of growth, not carved out of principal, and no return-of-capital funding was indicated.
What this grade doesn't say: It screens the dividend only — covered, real, compounding. It says nothing about valuation or price: a well-covered payer can still be overpriced, and its price can still fall.